期刊文献+

耐甲氧西林金黄色葡萄球菌耐药性及erm基因的检测与分析 被引量:19

Drug-resistance and Gene erm Existing in Meticillin-resistant Staphylococcus aureus
原文传递
导出
摘要 目的了解耐甲氧西林金黄色葡萄球菌(MRSA)耐药性及erm基因存在状况。方法采用ATB Staph药敏试验板微量肉汤法对50株金黄色葡萄球菌(SAU)进行15种抗菌药物敏感性测定,采用聚合酶链反应(PCR)技术检测MRSA的erm基因。结果检出的42株MRSA对万古霉素、替考拉宁、夫西地酸和奎奴普汀/达福普汀均100.0%敏感;对青霉素、苯唑西林、庆大霉素、四环素、环丙沙星和左氧氟沙星100.0%耐药;42株MRSA中erm基因阳性的35株,阳性率为83.3%。结论临床分离的MRSA多药耐药性已十分严重;MRSA对红霉素的耐药机制主要是由erm基因编码甲基化酶,使药物作用靶位改变所致。 OBJECTIVE To investigate the resistance of meticillin-resistant Staphylococcus aureus (MRSA) and the occurrence of gene erm. METHODS ATB Staph and microdilute tests were performed to detect the susceptibility to 15 kinds of antibiotics in 50 strains of the S. aureus (SAU). Gene erm of these strains was detected by polymerase chain reaction (PCR). RESULTS There were no strains resistant to vancomycin, teicoplanin, fusidic acid and quinupristin-dalfopristin in 42 strains of MRSA detected. There were no strains sensitive to penicillin, oxacillin, gentamicin, tetracycline, ciprofloxacin and levofloxacin. Thirty-five strains habored gene erm in 42 strains of MRSA. The positive rate of gene erm was 83. 3%. CONCLUSIONS The multiple-resistance of the MRSA is a serious issue. The resistance to erythromycin in MRSA is mediated by gene erm which encodes the methylase and changes the target site of drug action.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第5期484-486,共3页 Chinese Journal of Nosocomiology
关键词 耐甲氧西林金黄色葡萄球菌 耐药性 erm基因 Meticillin-resistant Staphylococcus aureus (MRSA) Drug-resistance Gene erm
  • 相关文献

参考文献7

二级参考文献32

  • 1姚春艳,府伟灵.葡萄球菌医院感染的耐药性分析[J].中华医院感染学杂志,2004,14(1):104-106. 被引量:86
  • 2王睿 见:李家泰 王复主编.细菌生物被膜的耐药屏蔽机制[A].见:李家泰,王复主编.中国细菌耐药与抗感染化疗研究进展[C].北京:中华医学电子音像出版社,2002.18-21.
  • 3Mitchell BA, Brown MH, Skurray. QacA Multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones[J]. Antimicrob Agents Chemother, 1998, 42(2): 475-477.
  • 4NCCLS. Performance standards for antimicrobial susceptibility testing[S]. Fourteenth informational supplement. 2004. 24(1): 104-109.
  • 5]NCCLS. Performance standards for antimicrobial susceptibility testing[S]. Fourteenth informational supplement. 2004. 24(1): 104-109.
  • 6National Committee for Clinical Laboratory Standard, 2002. Performance standards for antimicrobial susceptibility testing. Wayne.Pennsylvania:NCCLS, 2002.1- 50.
  • 7Jeijaszewicz J, Mlynarczyk G, Mlynarcqyk A. Antibiotic resistance in Gram-positive cocci. Int J Antimicrob Chemother, 2000,16:473-478.
  • 8Mutnick AH, Biedenbach DJ, Turnidge JD, et al. Spectrum and potency evaluation of a new oxazolidinone, linezolid:report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Diagn Microbiol Infect Dis, 2002,43:65-73.
  • 9Jones RN, Biedenbach DJ,Beach ML.Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001):report from the SENTRY Antimicrobial Surveillance Program. Diag Microbiol Infect Dis, 2003,46:77-80.
  • 10Biedenbach DJ, Stephen JM ,Jones RN. Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp.collected in the SENTRY Antimicrobial Surveillance Program-North America, 2001. Diag Microbiol Infect Dis, 2003,46:291-294.

共引文献318

同被引文献128

引证文献19

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部